"Executive Summary Secondary Hyperoxaluria Drug Market :   The global secondary hyperoxaluria drug market size was valued at USD 152.4 million in 2024 and is expected to reach USD 256.61 million by 2032, at a CAGR of 6.73% during the forecast period The market growth is largely fueled by the increasing prevalence of primary and secondary...